Europe · Macro, forex & crypto · Sharecast
Novo Nordisk lifts FY guidance amid continued momentum in GLP1s
Danish drug maker Novo Nordisk lifted its full-year guidance on Wednesday as it pointed to continued momentum in GLP1s.
Read the full article on Sharecast Sign in to saveMarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.sharecast.com)
